Ein guter Preis.  Online

Einzelheiten zu den Produkten

Created with Pixso. Zu Hause Created with Pixso. Produits Created with Pixso.
Gastrointestinale Krebsbehandlung
Created with Pixso. Sorafenib Tosylate Tablets 0.2g 60 Tablets Box Multi Kinase RAF VEGFR PDGFR Inhibitor for HCC RCC DTC Targeted Therapy

Sorafenib Tosylate Tablets 0.2g 60 Tablets Box Multi Kinase RAF VEGFR PDGFR Inhibitor for HCC RCC DTC Targeted Therapy

Markenname: Sichuan Kelun Pharmaceutical Co., Ltd.
Modellnummer: Sorafenib KL-20234069
Mindestbestellmenge: Verhandelbar
Preis: Please contact a specialist WhatsApp:55342706
Lieferzeit: Verhandelbar
Zahlungsbedingungen: Western Union, MoneyGram, T/T.
Detailinformationen
Herkunftsort:
Chengdu, Sichuan, China
Zertifizierung:
NMPA/GMP
Verpackung Informationen:
Verhandelbar
Versorgungsmaterial-Fähigkeit:
Verhandelbar
Hervorheben:

Multi Kinase RAF VEGFR Inhibitor

,

HCC RCC DTC Oral Therapy

,

BRAF CRAF VEGFR PDGFR Blockade

Produktbeschreibung
Sorafenib Tosylate 0.2g x 60 Tablets [Product Name] Generic Name: Sorafenib Tosylate Specification: 0.2g x 60 Tablets [Active Ingredient] Sorafenib Tosylate [Indications] 1. Advanced HCC. 2. Advanced RCC after cytokine failure. 3. Radioactive iodine-refractory DTC. [Mechanism of Action] Multi-kinase inhibitor targeting CRAF, BRAF, V600E BRAF, c-KIT, FLT-3 and VEGFR-1/2/3, PDGFR-b. Dual anti-proliferative and anti-angiogenic activity. [Dosage] 400mg (2 tablets) twice daily on